Harvard Medical School has created more wiggle room in one of its conflict-of-interest rules, after complaints from professors that the policy was hampering them from turning lab discoveries into treatments that could help people. Eric Campbell (Mass General) and Donald Ingber (Wyss Institute) are quoted, and Jeffrey S. Flier (HMS dean) and Robert Mayer (Brigham and Women’s/Dana-Farber) are mentioned.
Trending News
Medicare Spending Rises After Private Equity Buys Hospices
Longer stays suggest a shift toward patients who need less daily care
New Harvard Medical School Co-Director of Harvard-MIT Program in Health Sciences and Technology Welcomed
David Hirsh brings expertise in medical education innovation, deep-rooted humanism
First Large-Scale Study Shows How Doctors Use AI in Medicine
Which practitioners use artificial intelligence in the clinic, and what do they ask?